What are Key Considerations When Launching a Rare Disease Drug in a Specialty-Naive Market?


 
Gilbert: Key considerations for launching orphan therapy in a specialty-naïve market involves understanding the market, understanding the manufacturer demographic. Is this a new startup biotech firm? Is this a large manufacturer who’s been in this space for a while? Is the product the first product on the market available to these treatments? Or is this a market where other treatments have been available and so the marketplace is well known to specialty pharmacy?

Additionally, understanding where the physicians are, and their level of experience with specialty pharmacy and what their potential barriers might be. Do they understand that there may be capacity issues in the beginning where there’s a high demand of patients who have been waiting for treatments for a long time, and getting those patients on therapy? When you consider commercializing new orphan products, you have to look at all of these different dynamics in order to create a program, support systems, tools, and design to best support both the physician and the patient. That will lead to ultimately those patients having access to treatment.
 
 

Most Popular

Related Articles

In this clip, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx Specialty Pharmacy, explains how orphan drugs are making an impact on patients in the era of precision medicine.
By mapping out the epigenomic landscape of rheumatoid arthritis, scientists hope to gain insight on disease origins as well as new cell signaling pathways.
Diets high in foods such as vegetables, fruit, and healthy fats found to lower the risk of death from all causes, cardiovascular disease, and cancer.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$